Cullinan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CGEM Key Statistics
Stock Snapshot
With a market cap of 801.97M, Cullinan Therapeutics(CGEM) trades at $13.25. The stock has a price-to-earnings ratio of -3.45.
As of 2026-03-30, Cullinan Therapeutics(CGEM) stock has fluctuated between $12.63 and $13.26. The current price stands at $13.25, placing the stock +4.9% above today's low and -0.1% off the high.
Cullinan Therapeutics(CGEM) shares are trading with a volume of 368.38K, against a daily average of 908.7K.
During the past year, Cullinan Therapeutics(CGEM) stock moved between $5.68 at its lowest and $16.74 at its peak.
During the past year, Cullinan Therapeutics(CGEM) stock moved between $5.68 at its lowest and $16.74 at its peak.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.